The acquisition builds on Novonesis’ 2013 investment in MicroBioGen and its existing 23% ownership stake.
These projects build on Cargill’s broader renewable electricity efforts, including six VPPAs in North America and a global portfolio of more than 100 renewable energy projects across 30 countries.
Company completes spin-off of seed business, well positioned to advance its robust pipeline with 12 new actives, including 5 biologicals, for launch in the next decade.
Reported net sales decreased 1.4%; organic net sales decreased 1.1%.
The validation confirms that GNT’s environmental impact assessment framework adheres strictly to international ISO 14067 standards, providing the global food and beverage industry with audit-ready, standardized carbon emissions data for ingredient-level formulations.